Dr. Luis Gosálbez

Managing Director and Co-Founder

​

The GMO-microbiome drug development landscape

​

Dr. Luis Gosálbez presentation showed an overview of the role of the genetic modification of microorganisms to augment or expand their native metabolic capabilities, and use them as long-term drug delivery systems, as vaccines or as gene therapy agents in a wide range of diseases, from infections to metabolic disorders to cancer.